TAKE Solutions Limited (TAKE.NS)
INR 8.67
(2.0%)
INR 8.67
(2.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -8.18 INR | -19.24% |
| 2022 | -6.86 INR | 87.18% |
| 2021 | -53.50 INR | -73.08% |
| 2020 | -30.91 INR | -3536.47% |
| 2019 | -0.85 INR | -107.01% |
| 2018 | 12.13 INR | -0.49% |
| 2017 | 12.19 INR | 8.65% |
| 2016 | 11.22 INR | 12.54% |
| 2015 | 9.97 INR | 71.31% |
| 2014 | 5.82 INR | 20.5% |
| 2013 | 4.83 INR | -27.04% |
| 2012 | 6.62 INR | -7.15% |
| 2011 | 7.13 INR | 22.3% |
| 2010 | 5.83 INR | 115.93% |
| 2009 | 2.70 INR | -39.19% |
| 2008 | 4.44 INR | -6.33% |
| 2007 | 4.74 INR | 35.43% |
| 2006 | 3.50 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q3 | -0.15 INR | -36.36% |
| 2023 Q4 | -7.56 INR | -4940.0% |
| 2023 FY | - INR | -19.24% |
| 2023 Q1 | -0.36 INR | 90.55% |
| 2023 Q2 | -0.11 INR | 69.44% |
| 2022 Q4 | -3.81 INR | -444.29% |
| 2022 FY | - INR | 87.18% |
| 2022 Q2 | -0.56 INR | -51.35% |
| 2022 Q3 | -0.70 INR | -25.0% |
| 2022 Q1 | -0.37 INR | 99.26% |
| 2021 Q3 | -2.86 INR | -368.85% |
| 2021 Q4 | -49.81 INR | -1641.61% |
| 2021 FY | - INR | -73.08% |
| 2021 Q2 | -0.61 INR | -177.27% |
| 2021 Q1 | -0.22 INR | 95.41% |
| 2020 Q2 | -7.90 INR | 52.27% |
| 2020 Q3 | -1.74 INR | 77.97% |
| 2020 Q4 | -4.79 INR | -175.29% |
| 2020 FY | - INR | -3536.47% |
| 2020 Q1 | -16.55 INR | -45.18% |
| 2019 Q4 | -11.40 INR | -430.43% |
| 2019 Q2 | 3.42 INR | 10.68% |
| 2019 Q1 | 3.09 INR | 60.94% |
| 2019 FY | - INR | -107.01% |
| 2019 Q3 | 3.45 INR | 0.88% |
| 2018 Q1 | 3.66 INR | 6.09% |
| 2018 Q3 | 2.45 INR | -40.53% |
| 2018 Q4 | 1.92 INR | -21.63% |
| 2018 FY | - INR | -0.49% |
| 2018 Q2 | 4.12 INR | 12.57% |
| 2017 Q4 | 3.45 INR | 10.22% |
| 2017 FY | - INR | 8.65% |
| 2017 Q3 | 3.13 INR | 9.82% |
| 2017 Q2 | 2.85 INR | 3.26% |
| 2017 Q1 | 2.76 INR | -17.86% |
| 2016 FY | - INR | 12.54% |
| 2016 Q1 | 2.87 INR | 10.81% |
| 2016 Q2 | 2.18 INR | -24.04% |
| 2016 Q3 | 2.81 INR | 28.9% |
| 2016 Q4 | 3.36 INR | 19.57% |
| 2015 Q4 | 2.59 INR | 29.5% |
| 2015 FY | - INR | 71.31% |
| 2015 Q3 | 2.00 INR | -4.31% |
| 2015 Q2 | 2.09 INR | -36.47% |
| 2015 Q1 | 3.29 INR | 75.94% |
| 2014 Q2 | 1.12 INR | 3.7% |
| 2014 Q1 | 1.08 INR | 21.35% |
| 2014 FY | - INR | 20.5% |
| 2014 Q4 | 1.87 INR | 36.5% |
| 2014 Q3 | 1.37 INR | 22.32% |
| 2013 Q1 | 1.10 INR | 3.77% |
| 2013 Q2 | 1.26 INR | 14.55% |
| 2013 Q3 | 1.39 INR | 10.32% |
| 2013 FY | - INR | -27.04% |
| 2013 Q4 | 0.89 INR | -35.97% |
| 2012 Q1 | 2.10 INR | -1.87% |
| 2012 Q2 | 1.76 INR | -16.19% |
| 2012 FY | - INR | -7.15% |
| 2012 Q4 | 1.06 INR | -28.38% |
| 2012 Q3 | 1.48 INR | -15.91% |
| 2011 Q3 | 1.78 INR | 5.95% |
| 2011 FY | - INR | 22.3% |
| 2011 Q2 | 1.68 INR | 0.0% |
| 2011 Q4 | 2.14 INR | 20.22% |
| 2010 FY | - INR | 115.93% |
| 2009 FY | - INR | -39.19% |
| 2008 FY | - INR | -6.33% |
| 2007 FY | - INR | 35.43% |
| 2006 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biocon Limited | 8.55 INR | 195.673% |
| Blue Jet Healthcare Limited | 9.44 INR | 186.653% |
| Concord Biotech Limited | 29.45 INR | 127.776% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 16.445% |
| Jubilant Ingrevia Limited | 11.56 INR | 170.761% |
| Lyka Labs Limited | -0.75 INR | -990.667% |
| Panacea Biotec Limited | -0.19 INR | -4205.263% |
| Piramal Pharma Limited | 0.14 INR | 5942.857% |
| SMS Lifesciences India Limited | 30.08 INR | 127.194% |
| Supriya Lifescience Limited | 14.80 INR | 155.27% |
| Syngene International Limited | 12.71 INR | 164.359% |
| Zota Health Care Limited | -5.55 INR | -47.387% |